These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8870038)

  • 41. Apomorphine stimulation of male copulatory behavior is prevented by the oxytocin antagonist d(CH2)5 Tyr(Me)-Orn8-vasotocin in rats.
    Argiolas A; Collu M; D'Aquila P; Gessa GL; Melis MR; Serra G
    Pharmacol Biochem Behav; 1989 May; 33(1):81-3. PubMed ID: 2780793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of the adrenergic system in the regulation of vasopressin secretion in rat neurohypophyseal tissue cultures.
    Radács M; Gálfi M; Nagyéri G; Molnár AH; Varga C; László F; László FA
    Regul Pept; 2008 Jun; 148(1-3):1-5. PubMed ID: 18462818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.
    Shannon HE; Sawyer BD; Bemis KG; Bymaster FP; Health I; Mitch CH; Ward JS
    Eur J Pharmacol; 1993 Feb; 232(1):47-57. PubMed ID: 8458395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Muscarinic receptor subtypes and sexual behavior in female rats.
    Dohanich GP; McMullan DM; Cada DA; Mangum KA
    Pharmacol Biochem Behav; 1991 Jan; 38(1):115-24. PubMed ID: 1708147
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Morphine tolerance and inhibition of oxytocin secretion by kappa-opioids acting on the rat neurohypophysis.
    Russell JA; Coombes JE; Leng G; Bicknell RJ
    J Physiol; 1993 Sep; 469():365-86. PubMed ID: 8271202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and structure-activity studies of a series of 1-oxa-8-azaspiro[4.5]decanes as M1 muscarinic agonists.
    Tsukamoto S; Fujii M; Yasunaga T; Matsuda K; Wanibuchi F; Hidaka K; Furuya T; Tamura T
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):842-52. PubMed ID: 7553970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
    Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of adenosine agents on apomorphine-induced yawning in rats.
    Zarrindast MR; Fatehi F; Mohagheghi-Badi M
    Psychopharmacology (Berl); 1995 Dec; 122(3):292-6. PubMed ID: 8748398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brain oxytocin receptor antagonism blunts the effects of anorexigenic treatments in rats: evidence for central oxytocin inhibition of food intake.
    Olson BR; Drutarosky MD; Stricker EM; Verbalis JG
    Endocrinology; 1991 Aug; 129(2):785-91. PubMed ID: 1649746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apomorphine produced more yawning in Sprague-Dawley rats than in F344 rats: a pharmacological study.
    Tang AH; Himes CS
    Eur J Pharmacol; 1995 Sep; 284(1-2):13-8. PubMed ID: 8549616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. On muscarinic control of neurogenic mucus secretion in ferret trachea.
    Ramnarine SI; Haddad EB; Khawaja AM; Mak JC; Rogers DF
    J Physiol; 1996 Jul; 494 ( Pt 2)(Pt 2):577-86. PubMed ID: 8842014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes.
    Arnt J; Lembøl HL; Meier E; Pedersen H
    Eur J Pharmacol; 1992 Jul; 218(1):159-69. PubMed ID: 1397027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement of septal and striatal dopamine D-2 receptors in yawning behavior in rats.
    Yamada K; Tanaka M; Shibata K; Furukawa T
    Psychopharmacology (Berl); 1986; 90(1):9-13. PubMed ID: 2945222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thermic response of selective muscarinic agonists and antagonists in rat.
    Sen AP; Bhattacharya SK
    Indian J Exp Biol; 1991 Feb; 29(2):131-5. PubMed ID: 1869296
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxytocin-induced penile erection and yawning in male rats: effect of neonatal monosodium glutamate and hypophysectomy.
    Argiolas A; Melis MR; Mauri A; Gessa GL
    Psychopharmacology (Berl); 1989; 97(3):383-7. PubMed ID: 2497489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence of a peripheral and a central effect of oxytocin on pancreatic hormone release in rats.
    Björkstrand E; Eriksson M; Uvnäs-Moberg K
    Neuroendocrinology; 1996 Apr; 63(4):377-83. PubMed ID: 8739893
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Penile erection and yawning induced by oxytocin and related peptides: structure-activity relationship.
    Argiolas A; Melis MR; Stancampiano R; Gessa GL
    Peptides; 1989; 10(3):559-63. PubMed ID: 2780415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oxytocin: an extremely potent inducer of penile erection and yawning in male rats.
    Argiolas A; Melis MR; Gessa GL
    Eur J Pharmacol; 1986 Nov; 130(3):265-72. PubMed ID: 3792449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The antiallodynic effects of intrathecal cholinesterase inhibitors in a rat model of neuropathic pain.
    Hwang JH; Hwang KS; Leem JK; Park PH; Han SM; Lee DM
    Anesthesiology; 1999 Feb; 90(2):492-9. PubMed ID: 9952157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Central interaction between physostigmine and histamine during yawning in rats.
    Tamaddonfard E; Soraya H; Hamzeh-Gooshchi N
    Pharmacol Rep; 2008; 60(6):896-903. PubMed ID: 19211982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.